CM
APYX icon

Caption Management’s Apyx Medical APYX Stock Holding History

Caption Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$822K Sell
183,003
-2,748
-1% -$10.9K ﹤0.01% 1192
2026
Q1 		$685K Buy
185,751
+25,344
+16% +$94.7K ﹤0.01% 1121
2025
Q4 		$561K Buy
160,407
+36,475
+29% +$127K ﹤0.01% 1220
2025
Q3 		$265K Buy
123,932
+16,224
+15% +$34.3K ﹤0.01% 1428
2025
Q2 		$242K Sell
107,708
-239
-0.2% -$337 ﹤0.01% 1234
2025
Q1 		$148K Sell
107,947
-5,640
-5% -$7.77K ﹤0.01% 1317
2024
Q4 		$179K Sell
113,587
-1,963
-2% -$2.75K ﹤0.01% 1295
2024
Q3 		$143K Hold
115,550
– – ﹤0.01% 1096
2024
Q2 		$155K Sell
115,550
-558
-0.5% -$823 ﹤0.01% 986
2024
Q1 		$158K Buy
116,108
+84,777
+271% +$180K ﹤0.01% 1025
2023
Q4 		$82.1K Buy
31,331
+7,375
+31% +$17.9K ﹤0.01% 1195
2023
Q3 		$76.7K Buy
+23,956
New +$112K ﹤0.01% 1172
2019
Q2 		– Sell
-10,000
Closed -$63K – 647
2019
Q1 		$63K Buy
+10,000
New +$77.4K ﹤0.01% 532

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Caption Management's APYX Position: Q2 2026 in Review

Caption Management reduced its Apyx Medical (APYX) stake by 1.5% in Q2 2026, selling an estimated $10.9K and leaving 183,003 shares worth $822K. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Caption Management first reported a position in APYX in Q1 2019 and has held it in 13 quarters since. 67 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Caption Management held 183,003 shares of Apyx Medical worth $822K as of Q2 2026.
  • Caption Management sold 2,748 Apyx Medical shares in Q2 2026, an estimated $10.9K.
  • Apyx Medical made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1192 holding.
  • Caption Management first reported a position in Apyx Medical in Q1 2019 and has held it in 13 quarters since.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.